from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0133/-

LFCtreatmentdescriptionclass of inhibitor

0.404

Amikacinug/mL Amikacintranslation

0.587

Cap5-10ug/mL Capreomycintranslation

0.366

Rox10-50 ug/mL Roxithromycintranslation

-0.237

SM2-5 ug/mL Streptomycintranslation

1.746

Tet5-10 ug/mL Tetracyclinetranslation

0.204

Rif0.2-5ug/mL Rifampicintranscription

0.157

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.815

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.558

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.185

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.304

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.340

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.117

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.480

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-3.510

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.399

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

2.289

NaN30.2-2 mM Sodium aziderespiration

-0.340

Nigericin50 uM Nigericinrespiration

-0.055

TRC10-150 ug/mL Triclosanrespiration

0.783

TRZ10-25 ug/mL Thioridazinerespiration

-0.223

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.253

menadione6-10 ug/mL Menadionerespiration

-0.431

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.245

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.684

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.525

NRP_1Non-replicating persistence stage 1dosRassociated

-0.205

Amp0.2mg/mL AmpicillincellWall

0.215

Cephalexin20-100 ug/mL CephalexincellWall

0.591

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.803

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.660

EMB10-20 ug/mL EthambutolcellWall

0.574

Eta12-40 ug/mL EthionamidecellWall

1.131

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.136

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.000

BZA0.12 mg/mL BenzamidearomaticAmides

-0.768

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.468

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.214

H2O24 mM hydrogen peroxideDNAdamaging

0.859

Levo10 ug/mL LevofloxacinDNAdamaging

0.307

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.836

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.407

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.102

Antimycin12.5-50 ug/mL Antimycin A?

0.701

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.134

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.262

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.622

PA8240.2-2 ug/mL PA-824?

-0.399

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.142

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.062

Verapamil50 uM Verapamil?

-1.594

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?